Summary of Key Points Core Viewpoint - Huarun Pharmaceutical's stock closed at 3.15 yuan on December 31, with a slight increase of 0.32%. The stock experienced three block trades totaling 1.2967 million shares and a transaction value of 3.6826 million yuan, indicating active trading interest despite recent declines [1]. Trading Activity - The first block trade occurred at a price of 2.84 yuan for 300,000 shares, amounting to 852,000 yuan, with a discount rate of -9.84%. The buyer was an institutional investor, and the seller was China Galaxy Securities Co., Ltd. [1] - The second block trade also took place at 2.84 yuan, involving 529,200 shares and a total value of 1.5029 million yuan, maintaining the same discount rate of -9.84%, with the buyer being an institutional investor and the seller being Guosheng Securities Co., Ltd. [1] - The third block trade matched the previous prices, with 467,500 shares traded at 2.84 yuan, resulting in a transaction value of 1.3277 million yuan and a discount rate of -9.84%, with the buyer again being an institutional investor and the seller being China Galaxy Securities Co., Ltd. [1] Recent Performance - Over the past three months, Huarun Pharmaceutical has recorded a total of 19 block trades, with a cumulative transaction value of 36.5743 million yuan. In the last five trading days, the stock has seen a decline of 1.87%, with a net outflow of 1.336 million yuan in principal funds [1].
华仁药业12月31日现3笔大宗交易 总成交金额368.26万元 其中机构买入368.26万元 溢价率为-9.84%